Review article: The role of surgery in gastro-oesophageal reflux disease

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 12, 2007, Pages 1365-1372

  Vakil, N ^a,b,c  

^a School of Medicine and Public Health ^*  (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c MARQUETTE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

CLINICAL TRIAL; GASTROESOPHAGEAL REFLUX; HEARTBURN; HIATUS HERNIA; HUMAN; IMPEDANCE; PATIENT SELECTION; PH MEASUREMENT; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; STOMACH FUNDOPLICATION; SYMPTOM; TREATMENT RESPONSE;

ADULT; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; PATIENT EDUCATION; POSTOPERATIVE COMPLICATIONS; PROTON PUMPS; RISK FACTORS; TREATMENT OUTCOME;

EID: 34249826938     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03333.x     Document Type: Review

References (47)

1. Society of American Gastrointestinal and Endoscopic Surgeons. Guidelines for surgical treatment of gastro-oesophageal reflux disease (GERD). Available at: http://www.sages.org/sagespublication.php?doc=22, accessed on 24 December 2006
2. de Vos Shoop M, Peters J, DeMeester T, Crookes P, Kline M. Patient response to marketing minimally invasive surgery for heartburn. Surg Endosc 1998 12 : 261 5.
3. Finks J, Wei Y, Birkmeyer J. The rise and fall of antireflux surgery in the United States. Surg Endosc 2006 20 : 1698 701.
4. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001 285 : 2331 8.
5. Vakil N, Kirby R, Shaw M. Clinical effectiveness of laparoscopic fundoplication in a US community. Am J Med 2003 114 : 1 5.
6. Klaus A, Hinder RA, DeVault KR, Achem SR. Bowel dysfunction after laparoscopic antireflux surgery: incidence, severity, and clinical course. Am J Med 2003 114 : 6 9.
7. DeVault K, Castell D. Updated guidelines for the diagnosis and treatment of gastro-esophageal reflux disease. Am J Gastroenterol 2005 100 : 190 200.
8. Madan A, Minocha A. Despite high satisfaction, majority of gastro-oesophageal reflux disease patients continue to use proton pump inhibitors after antireflux surgery. Aliment Pharmacol Ther 2006 23 : 601 5.
9. Ye W, Chow WH, Lagergren J, Yin L, Nyren O. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastro-esophageal reflux disease after antireflux surgery. Gastroenterology 2001 121 : 1286 93.
10. Tran T, Spechler SJ, Richardson P, El-Serag HB. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol 2005 100 : 1002 8.
11. Viljakka M, Nevalainen J, Isolauri J. Lifetime costs of surgical vs. medical treatment of severe gastro-oesophageal reflux disease in Finland. Scand J Gastroenterol 1997 32 : 766 72.
12. Heudebert GR, Marks R, Wilcox CM, Centor RM. Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastroenterology 1997 112 : 1078 86.
13. Arguedas MR, Heudebert GR, Klapow JC, et al. Re-examination of the cost-effectiveness of surgical vs. medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection. Am J Gastroenterol 2004 99 : 1023 8.
14. Myrvold HE, Lundell L, Miettinen P, et al. The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut 2001 49 : 488 94.
15. Rantanen TK, Sihvo EI, Rasanen JV, Salo JA. Gastroesophageal reflux disease as a cause of death is increasing: analysis of fatal cases after medical and surgical treatment. Am J Gastroenterol 2007 102 : 246 253.
16. Dominitz JA, Dire CA, Billingsley KG, Todd-Stenberg JA. Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol 2006 4 : 299 305.
17. Corey KE, Schmitz SM, Shaheen NJ. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am J Gastroenterol 2003 98 : 2390 4.
18. Sgouros SN, Mantides A. Proton pump inhibitor failure in gastro-oesophageal reflux disease - what about eosinophilic oesophagitis? Aliment Pharmacol Ther 2006 23 : 1281.
19. Jones MP, Sloan SS, Rabine JC, Ebert CC, Huang CF, Kahrilas PJ. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol 2001 96 : 1711 7.
20. Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 2005 100 : 283 9.
21. Ciccaglione AF, Marzio L. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 h pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003 52 : 464 70.
22. Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006 93 : 1483 7.
23. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006 101 : 1900 20.
24. Allen CJ, Anvari M. Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication. Thorax 1998 53 : 963 8.
25. Sontag SJ, O'Connell S, Khandelwal S, et al. Asthmatics with gastro-esophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 2003 98 : 987 99.
26. Larrain A, Carrasco E, Galleguillos F, Sepulveda R, Pope CE II. Medical and surgical treatment of nonallergic asthma associated with gastro-esophageal reflux. Chest 1991 99 : 1330 5.
27. Swoger J, Ponsky J, Hicks DM, et al. Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol 2006 4 : 433 41.
28. Qadeer MA, Swoger J, Milstein C, et al. Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux. Laryngoscope 2005 115 : 1947 52.
29. Tutuian R, Mainie I, Agarwal A, Adams D, Castell D. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 2006 130 : 386 91.
30. Tutuian R, Mainie I, Agrawal A, Adams D, Castell DO. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 2006 130 : 386 91.
31. Parameswaran R, Ali A, Velmurugan S, Adjepong SE, Sigurdsson A. Laparoscopic repair of large paraesophageal hiatus hernia: quality of life and durability. Surg Endosc 2006 20 : 1221 4.
32. El-Serag HB, Sonnenberg A. Outcome of erosive reflux esophagitis after Nissen fundoplication. Am J Gastroenterol 1999 94 : 1771 6.
33. Guda NM, Vakil N. Proton pump inhibitors and the time trends for esophageal dilation. Am J Gastroenterol 2004 99 : 797 800.
34. Ramage JI Jr., Rumalla A, Baron TH, et al. A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol 2005 100 : 2419 25.
35. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr 2007 150 : 262 7.
36. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000 118 : 661 9.
37. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006 296 : 2947 53.
38. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004 292 : 1955 60.
39. Lind T. Changing surgical principles for gastro-oesophageal reflux disease - is laparoscopic fundoplication justified in the light of surgical complications Eur J Surg Suppl 2000 585 : 31 3.
40. Leggett PL, Bissell CD, Churchman-Winn R. Aortic injury during laparoscopic fundoplication: an underreported complication. Surg Endosc 2002 16 : 362.
41. Rantanen T, Sihvo E, Rasanen J, Salo J. Gastro-esophageal reflux disease as a cause of death is increasing: analysis of fatal cases after medical and surgical treatment. Am J Gastroenterol 2007 102 : 246 53.
42. Pessaux P, Arnaud JP, Delattre JF, Meyer C, Beaulieux J, Mosnier H. Laparoscopic antireflux surgery. Arch Surg 2005 140 : 946 51.
43. Rantanen TK, Halme TV, Luostarinen ME, Karhumaki LM, Kononen EO, Isolauri JO. The long term results of open antireflux surgery in a community-based health care center. Am J Gastroenterol 1999 94 : 1777 81.
44. Bais J, Bartelsman J, Bonjer, et al. Laparoscopic or conventional Nissen fundoplication for gastro-esophageal reflux disease: randomized clinical trial. Lancet 2000 355 : 170 4.
45. Cobb L, Thomas G, Dillard D, Merending K, Bruce R. An evaluation of internal-mammary artery ligation by a double-blind technic. N Engl J Med 1959 260 : 1115 8.
46. Mehta S, Bennett J, Mahon D, Rhodes M. Prospective trial of laparoscopic Nissen fundoplication vs. proton pump inhibitor therapy for gastroesophageal reflux disease: seven-year follow-up. J Gastrointest Surg 2006 10 : 1312 7.
47. Lundell L, Miettinen P, Myrvold H, et al. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg 2007 94 : 198 203.